The FDA has released a drug safety advisory on the use of Sanofi's blood-thinning agent Lovenox in patients with spinal catheters. The FDA recommends that the placement or removal of catheters should be postponed for at least 12 hours after enoxaparin administration and 24 hours for patients receiving higher doses to reduce bleeding. The drug's warnings will be updated to include said recommendations.
FDA issues drug safety advisory to reduce risk of bleeding with enoxaparin
SmartBrief Job Listings for Health Care
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Sr. Business Systems Analyst||
|Sr. Reimbursement Analyst||
Olympus America Inc.
|Staff VP Medical Policy Development-81321||